Monthly Prescribing Reference |
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US … New Inhalers for Asthma, COPD Launched GSK Expands Portfolio of Asthma/COPD Medicines in U.S. GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News